Advertisement
Screener

Imunon, Inc. (IMNN) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.1 / 5 stars · 12/57 Roast Me

Imunon, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Imunon, Inc. (IMNN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.16 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11

  • Imunon, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 3.16M shares, a 163.99% increase year-over-year.
  • Imunon, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.17M shares, a 565.27% increase year-over-year.
  • Imunon, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.20M shares.
  • Imunon, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 475.81K shares, a 60.26% decline year-over-year.
  • Imunon, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 1.57M shares.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-303.16M shares
10-Q · filed 2026-08-11
3.16M shares
10-Q · filed 2026-08-11
2026-03-313.17M shares
10-Q · filed 2026-05-12
2025-09-30990.23K shares
10-Q · filed 2025-11-13
2025-06-301.20M shares
10-Q · filed 2026-08-11
1.20M shares
10-Q · filed 2026-08-11
2025-03-31475.81K shares
10-Q · filed 2026-05-12
7.14M shares
10-Q · filed 2025-05-12
2024-09-30447.50K shares
10-Q · filed 2025-11-13
6.71M shares
10-Q · filed 2024-11-07
2024-06-30102.17K shares
10-Q · filed 2025-08-05
1.53M shares
10-Q · filed 2024-08-14
2024-03-311.20M shares
10-Q · filed 2025-05-12
2023-09-301.15M shares
10-Q · filed 2023-11-14
1.15M shares
10-Q · filed 2024-11-07
2023-06-301.25M shares
10-Q · filed 2024-08-14
2023-03-311.29M shares
10-Q · filed 2024-05-13
2022-09-301.35M shares
10-Q · filed 2023-11-14
1.35M shares
10-Q · filed 2023-11-14
2022-06-301.10M shares
10-Q · filed 2022-08-15
1.10M shares
10-Q · filed 2023-08-10
2022-03-31836.10K shares
10-Q · filed 2023-05-11
2021-09-30616.69K shares
10-Q · filed 2022-11-14
2021-06-30621.68K shares
10-Q · filed 2022-08-15
621.68K shares
10-Q · filed 2022-08-15
2021-03-31611.18K shares
10-Q · filed 2022-05-16
2017-06-301.28M shares
10-Q · filed 2017-08-14
1.28M shares
10-Q · filed 2017-08-14
2016-12-311.57M shares
10-K · filed 2018-03-27
21.98M shares
10-K · filed 2017-03-24
2016-09-3017.10M shares
10-Q · filed 2016-11-10
17.10M shares
10-Q · filed 2016-11-10
2016-06-301.25M shares
10-Q · filed 2017-08-14
17.43M shares
10-Q · filed 2016-08-15
1.25M shares
10-Q · filed 2017-08-14
17.43M shares
10-Q · filed 2016-08-15
2016-03-318.63M shares
10-Q · filed 2016-05-16
2015-09-308.11M shares
10-Q · filed 2016-11-10
8.11M shares
10-Q · filed 2016-11-10
2015-06-308.19M shares
10-Q · filed 2016-08-15
8.19M shares
10-Q · filed 2016-08-15
2015-03-316.34M shares
10-Q · filed 2016-05-16
2014-09-308.19M shares
10-Q · filed 2015-11-05
8.19M shares
10-Q · filed 2015-11-05
6.83M shares
10-Q · filed 2014-11-10
2014-06-306.95M shares
10-Q · filed 2015-08-10
6.95M shares
10-Q · filed 2015-08-10
2014-03-316.24M shares
10-Q · filed 2015-05-11
2013-09-303.94M shares
10-Q · filed 2013-11-12
3.94M shares
10-Q · filed 2014-11-10
3.03M shares
10-Q · filed 2013-11-12
2013-06-3017.91M shares
10-Q · filed 2013-08-08
3.98M shares
10-Q · filed 2014-08-07
2013-03-314.69M shares
10-Q · filed 2014-05-08
2012-09-3021.09M shares
10-Q · filed 2013-05-09
13.64M shares
10-Q · filed 2012-11-09
2012-06-3015.20M shares
10-Q · filed 2013-08-08
15.20M shares
10-Q · filed 2012-08-14
2011-09-3014.98M shares
10-Q · filed 2013-05-09
11.49M shares
10-Q · filed 2012-11-09
2011-06-309.25M shares
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97